MedTech News

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ — MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the trial evaluating ENLIGHTEN®, a first-of-its-kind blood test, registered with the MHRA, and designed to spot signals of up to 10 cancers at their earliest, most treatable stages

Read More »

Body Vision Medical Receives Regulatory Approval for LungVision® in Brazil, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis

WALTHAM, Mass., July 29, 2025 /PRNewswire/ — Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision advanced imaging system has received regulatory approval from ANVISA, Brazil’s National Health Surveillance Agency. This approval marks another significant step forward in the company’s mission to improve early and accurate lung cancer diagnosis around the world.

Read More »

Detecting cancer cells in blood: Microfluidic device captures cancer cells with 90% efficiency

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel through the blood in the circulatory system and lodge themselves in other organs to cause secondary tumors. Therefore, the detection and subsequent characterization of CTCs from blood can help in the clinical diagnosis and treatment of various cancers. However, the efficient capture of CTCs from blood has been proven to be difficult.

Read More »

Sign up for Blog Updates